UnitedHealth Group (NYSE:UNH) Stock Rating Upgraded by Raymond James Financial

UnitedHealth Group (NYSE:UNH) was upgraded by stock analysts at Raymond James Financial from a “market perform” rating to an “outperform” rating in a note issued to investors on Wednesday, MarketBeat Ratings reports. The firm presently has a $330.00 price objective on the healthcare conglomerate’s stock. Raymond James Financial’s price objective suggests a potential upside of 22.11% from the stock’s previous close.

Several other research firms also recently issued reports on UNH. Wells Fargo & Company cut their target price on UnitedHealth Group from $400.00 to $370.00 and set an “overweight” rating on the stock in a research report on Friday, January 30th. Mizuho cut their price objective on UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating on the stock in a report on Thursday, February 5th. Jefferies Financial Group decreased their target price on UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating for the company in a report on Wednesday, January 28th. Morgan Stanley cut their price target on shares of UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating on the stock in a report on Friday, January 23rd. Finally, Leerink Partners dropped their price objective on shares of UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating on the stock in a report on Wednesday, January 28th. One analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $363.38.

UnitedHealth Group Stock Performance

UNH opened at $270.24 on Wednesday. The firm’s 50-day moving average price is $287.64 and its 200-day moving average price is $321.03. The company has a market cap of $245.29 billion, a P/E ratio of 20.49, a price-to-earnings-growth ratio of 1.20 and a beta of 0.41. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.72. UnitedHealth Group has a 52-week low of $234.60 and a 52-week high of $606.36.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping the consensus estimate of $2.09 by $0.02. The company had revenue of $113.73 billion for the quarter, compared to the consensus estimate of $113.38 billion. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. UnitedHealth Group’s revenue was up 12.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.81 EPS. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, equities analysts anticipate that UnitedHealth Group will post 29.54 EPS for the current fiscal year.

Institutional Trading of UnitedHealth Group

A number of hedge funds have recently added to or reduced their stakes in the company. Guerra Advisors Inc acquired a new stake in UnitedHealth Group in the 3rd quarter valued at about $1,059,000. Berkshire Hathaway Inc purchased a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $1,572,193,000. Carnegie Investment Counsel lifted its position in UnitedHealth Group by 2.2% during the third quarter. Carnegie Investment Counsel now owns 105,621 shares of the healthcare conglomerate’s stock worth $36,471,000 after buying an additional 2,316 shares in the last quarter. EverSource Wealth Advisors LLC boosted its stake in UnitedHealth Group by 48.9% during the second quarter. EverSource Wealth Advisors LLC now owns 5,790 shares of the healthcare conglomerate’s stock worth $1,806,000 after buying an additional 1,901 shares during the last quarter. Finally, Phoenix Financial Ltd. increased its stake in shares of UnitedHealth Group by 111.5% in the 3rd quarter. Phoenix Financial Ltd. now owns 41,986 shares of the healthcare conglomerate’s stock worth $14,282,000 after acquiring an additional 22,137 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.